NCT04799873View on ClinicalTrials.gov

Alpha-1-Antitrypsin-Deficiency in COVID-19

CompletedOBSERVATIONAL
Enrollment

10

Participants

Timeline

Start Date

April 8, 2020

Primary Completion Date

December 1, 2020

Study Completion Date

December 1, 2020

Conditions
Covid19
Interventions
DRUG

AAT( Alpha 1 Antitrypsin)

AAT administration based on clinical indication

Trial Locations (1)

66421

Saarland University, Homburg

All Listed Sponsors
lead

Universität des Saarlandes

OTHER

NCT04799873 - Alpha-1-Antitrypsin-Deficiency in COVID-19 | Biotech Hunter | Biotech Hunter